LifeMD Q2 2024 Adj. EPS $0.06 Beats $(0.12) Estimate, Sales $50.662M Beat $48.251M Estimate
Author: Benzinga Newsdesk | August 07, 2024 05:41pm
LifeMD (NASDAQ:
LFMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.12) by 150 percent. The company reported quarterly sales of $50.662 million which beat the analyst consensus estimate of $48.251 million by 5.00 percent. This is a 40.94 percent increase over sales of $35.947 million the same period last year.
Posted In: LFMD